Alector (ALEC) Research & Development (2018 - 2026)
Alector's Research & Development came in at $19.46 million for Q2 2026, down 29.5% from $27.61 million a year earlier but up 9.0% from the prior quarter.
Alector (ALEC) Research & Development (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Alector reported Research & Development of $99.13 million, down 36.3% year-over-year; for FY2025, it came in at $123.07 million, down 33.8% from FY2024.
- Research & Development has declined in each of the last three years, with a five-year compound annual growth rate of -4.7% (FY2020 to FY2025).
- Going back by year, Research & Development was $185.94 million in FY2024 (-3.2%), $192.12 million in FY2023 (-8.7%), $210.42 million in FY2022 (+11.1%) and $189.41 million in FY2021 (+20.7%).
- The five-year range for quarterly Research & Development is $17.86 million (Q1 2026) to $54.53 million (Q2 2022).
- Year-over-year, Research & Development has declined for seven consecutive quarters, with an average decline of 26.3% over the last eight quarters.
- The fastest year-over-year change in Research & Development over five years came in Q4 2021 (growth of 18.9%), and the weakest in Q1 2026 (a decline of 46.9%).
- Business Quant data shows ALEC's Research & Development at $17.86 million (Q1 2026), $32.46 million (Q4 2025) and $29.35 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Alector | 218.56 Mn | -707.89 Mn | - | 19.46 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.46 Mn |
| Mar 31, 2026 | 17.86 Mn |
| Dec 31, 2025 | 32.46 Mn |
| Sep 30, 2025 | 29.35 Mn |
| Jun 30, 2025 | 27.61 Mn |
| Mar 31, 2025 | 33.64 Mn |
| Dec 31, 2024 | 46.46 Mn |
| Sep 30, 2024 | 48.00 Mn |
| Jun 30, 2024 | 46.31 Mn |
| Mar 31, 2024 | 45.17 Mn |
| Dec 31, 2023 | 47.72 Mn |
| Sep 30, 2023 | 46.33 Mn |
| Jun 30, 2023 | 46.18 Mn |
| Mar 31, 2023 | 51.89 Mn |
| Dec 31, 2022 | 54.49 Mn |
| Sep 30, 2022 | 48.35 Mn |
| Jun 30, 2022 | 54.53 Mn |
| Mar 31, 2022 | 53.04 Mn |
| Dec 31, 2021 | 52.79 Mn |
| Sep 30, 2021 | 43.07 Mn |
Alector Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ALEC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ALEC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ALEC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();